Posts

A Rare Court Ruling Allowed the Drug Maker Fresenius to Nix a $4.75 Billion Deal

Pfizer’s Departing C.E.O. Will Be Known for the Deals He Didn’t Complete

Ex-Valeant Executive Is Convicted of Bilking Drugmaker in Kickback Scheme

Curating Band-Aids, Both Modern and Vintage

Patent ‘Trolls’ Recede as Threat to Innovation. Will Justices Change That?

Key European Agencies Move to Continent, Signs of Brexit’s Toll

Pfizer Considers Spinning Off or Selling Consumer Health Unit

Martin Shkreli Is Found Guilty of Fraud

Stada Board Recommends Acceptance of Improved Takeover Bid

The Private Equity Firm That Quietly Profits on Top-Selling Drugs

Wanting Martin Shkreli to Stop Talking, Prosecutors Seek Judge’s Help

Shkreli Had No Trouble Courting Investors, Financier Says at Trial

Scenes From Martin Shkreli’s Journey to Federal Court

Angry About EpiPen Prices? Executive Don’t Care Much

Revisiting Nafta: The Stakes for Key Industries

Stada to Support Takeover Bid by Bain Capital and Cinven

How a Big Wager on Valeant Played Out

William Ackman Sells Pershing Fund’s Stake in Valeant

Lloyd Conover, Inventor of Groundbreaking Antibiotic, Dies at 93